SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the wearable injectors field, including the enhanced demand for on-body injectors and digitalised health as the need for at home self-administration and routes for delivery of time-dependent, high volume and viscous drugs grow.

The conference will also cover key regulatory updates such as guidance on MDR requirements from regulatory and notified bodies, and the importance of considering user-experience and developing patient-centric devices. The two-day conference will bring you high-quality insights and industry connections on the latest advances in wearable injectors and connectivity, and a platform for exchanging ideas.

Why  attend:

• 2 full days of networking opportunities.
• 16+ sessions with 75% of speakers from big pharma companies.
• An agenda designed for professionals within the injectables space, focused on the development, implementation and application of wearable injectors and connected devices.
• The only conference discussing wearable injectors and connected devices together, other than our USA version of this event.

The Experience:

• A collaborative environment for pharma, biotech and device developers to discuss the latest trends and challenges within the wearable injectors and connected device market.
• Learn from key industry players about new technologies, strategies and processes for the development of wearable injectors.
• Gain insights into the regulatory processes for the approval of wearable injectors and develop a greater understanding of how-to bring devices to market.
• Create a dialogue with industry leaders and develop a network with the key stakeholders in the market.
• Delve into the world of digital health for the healthcare sector and discuss implementation of connectivity with on-body drug delivery systems.
• Examine the importance of usability for at home injectors, and what is needed to make a device appropriate for patient administration.